Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 73
2.
J Eur Acad Dermatol Venereol ; 36(2): 213-221, 2022 Feb.
Article En | MEDLINE | ID: mdl-34664323

BACKGROUND: A polygenic inheritance involving high, medium and low penetrance genes has been suggested for melanoma susceptibility in adults, but genetic information is scarce for paediatric patients. OBJECTIVE: We aim to analyse the major high and intermediate melanoma risk genes, CDKN2A, CDK4, POT1, MITF and MC1R, in a large multicentre cohort of Italian children and adolescents in order to explore the genetic context of paediatric melanoma and to reveal potential differences in heritability between children and adolescents. METHODS: One-hundred-twenty-three patients (<21 years) from nine Italian centres were analysed for the CDKN2A, CDK4, POT1, MITF, and MC1R melanoma predisposing genes. The rate of gene variants was compared between sporadic, familial and multiple melanoma patients and between children and adolescents, and their association with clinico-pathological characteristics was evaluated. RESULTS: Most patients carried MC1R variants (67%), while CDKN2A pathogenic variants were found in 9% of the cases, the MITF E318K in 2% of patients and none carried CDK4 or the POT1 S270N pathogenic variant. Sporadic melanoma patients significantly differed from familial and multiple cases for the young age at diagnosis, infrequent red hair colour, low number of nevi, low frequency of CDKN2A pathogenic variants and of the MC1R R160W variant. Melanoma in children (≤12 years) had more frequently spitzoid histotype, were located on the head/neck and upper limbs and had higher Breslow thickness. The MC1R V92M variant was more common in children than in adolescents. CDKN2A common polymorphisms and MC1R variants were associated with a high number of nevi. CONCLUSION: Our results confirm the scarce involvement of the major high-risk susceptibility genes in paediatric melanoma and suggest the implication of MC1R gene variants especially in the children population.


Melanoma , Skin Neoplasms , Adolescent , Adult , Child , Genes, p16 , Genetic Predisposition to Disease , Humans , Melanoma/genetics , Receptor, Melanocortin, Type 1/genetics , Skin Neoplasms/genetics
4.
Plant Biol (Stuttg) ; 20(6): 995-1004, 2018 Nov.
Article En | MEDLINE | ID: mdl-30098088

Mediterranean tomato landraces adapted to arid environments represent an option to counteract drought, and to address the complexity of responses to water deficit and recovery, which is a crucial component of plant adaptation mechanisms. We investigated physiological, biochemical and molecular responses of two Mediterranean tomato landraces, 'Locale di Salina' (Lc) and 'Pizzutello di Sciacca' (Pz) under two dehydration periods and intermediate rehydration in greenhouse pot experiments. Relationship between CO2 assimilation (A) and stomatal conductance under severe water stress (gs  < 0.05 mol·m-2 ·s-1 ) indicated the occurrence of stomatal and non-stomatal limitations of photosynthesis. Gas exchange promptly recovered within 2-3 days of rehydration. ABA and gs showed a strict exponential relationship. Both leaf ABA and proline peaked under severe water stress. Lc showed higher accumulation of ABA and higher induction of the expression of both NCED and P5CS genes than Pz. Poly(ADP-ribose) polymerase increased during imposition of stress, mainly in Lc, and decreased under severe water stress. The two landraces hardly differed in their physiological performance. Under severe water stress, gs showed low sensitivity to ABA, which instead controlled stomatal closure under moderate water stress (gs  > 0.15 mol·m-2 ·s-1 ). The prompt recovery after rehydration of both landraces confirmed their drought-tolerant behaviour. Differences between the two landraces were instead observed at biochemical and molecular levels.


Solanum lycopersicum/physiology , Abscisic Acid/metabolism , Carbon Dioxide/metabolism , Chlorophyll/metabolism , Chlorophyll A , Dehydration , Fluorescence , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Mediterranean Region , Photosynthesis , Plant Growth Regulators/metabolism , Plant Leaves/metabolism , Plant Leaves/physiology , Plant Stomata/physiology , Poly(ADP-ribose) Polymerases/metabolism , Polymerase Chain Reaction , Proline/metabolism
5.
Clin Exp Allergy ; 48(9): 1092-1106, 2018 09.
Article En | MEDLINE | ID: mdl-29904978

Nasal cytology is an easy, cheap, non-invasive and point-of-care method to assess nasal inflammation and disease-specific cellular features. By means of nasal cytology, it is possible to distinguish between different inflammatory patterns that are typically associated with specific diseases (ie, allergic and non-allergic rhinitis). Its use is particularly relevant when other clinical information, such as signs, symptoms, time-course and allergic sensitizations, is not enough to recognize which of the different rhinitis phenotypes is involved; for example, it is only by means of nasal cytology that it is possible to distinguish, among the non-allergic rhinitis, those characterized by eosinophilic (NARES), mast cellular (NARMA), mixed eosinophilic-mast cellular (NARESMA) or neutrophilic (NARNE) inflammation. Despite its clinical usefulness, cheapness, non-invasiveness and easiness, nasal cytology is still underused and this is at least partially due to the fact that, as far as now, there is not a consensus or an official recommendation on its methodological issues. We here review the scientific literature about nasal cytology, giving recommendations on how to perform and interpret nasal cytology.


Cytodiagnosis , Nasal Mucosa/pathology , Rhinitis/diagnosis , Animals , Biofilms , Biopsy , Cytodiagnosis/methods , Humans , Nasal Mucosa/immunology , Nasal Mucosa/microbiology , Practice Patterns, Physicians' , Research , Rhinitis/etiology , Therapeutic Irrigation
7.
Arch Dermatol Res ; 307(6): 495-503, 2015 Aug.
Article En | MEDLINE | ID: mdl-25736238

Environmental and genetic risk factors are involved in the development of melanoma. The role of the melanocortin 1 receptor (MC1R) gene has been investigated and differences according to geographic areas have been described. To evaluate the role of some clinical and genetic risk factors in melanoma development, we performed a case-control study involving 101 melanoma patients and 103 controls coming from South-Eastern Italy (Puglia), after achieving informed consent. We confirmed the role of known clinical risk factors for melanoma. Furthermore, 42 MC1R polymorphisms were observed. Three of these variants (L26V, H232L, D294Y) were not previously reported in the literature. Their predicted impact on receptor function was evaluated using bioinformatic tools. We report an overall frequency of MC1R variants in our population higher than in Northern or Central Italy. The most common polymorphism found was V60L, that has been recently reported to spread among South Mediterranean population. This variant influenced phenotypic characteristics of our population while it did not impinge on melanoma risk. An increased risk of melanoma was associated with two or more MC1R variants, when at least one was RHC, compared to people carrying the MC1R consensus sequence or a single MC1R polymorphism. Interestingly, we observed an increased risk of melanoma in subjects with darker skin and lower nevus count, usually considered at low risk, when carrying MC1R polymorphisms.


Melanoma/genetics , Polymorphism, Genetic/physiology , Receptor, Melanocortin, Type 1/genetics , Skin Neoplasms/genetics , Adult , Aged , Case-Control Studies , Female , Genotyping Techniques , Humans , Italy/epidemiology , Logistic Models , Male , Melanoma/epidemiology , Middle Aged , Risk Factors , Skin Neoplasms/epidemiology
9.
Cell Death Dis ; 5: e1076, 2014 Feb 20.
Article En | MEDLINE | ID: mdl-24556691

Understanding of BRCA1/2 interaction with the base excision repair (BER) pathway could improve therapy based on 'synthetic lethality', whose effectiveness is based on homologous recombination deficiency in cells lacking functional BRCA genes. However, poly (ADP-ribose) polymerase (PARP) inhibitors failed in some patients and for this reason we explored BER key enzyme expression. In this study, the expression of BER enzymes (redox factor 1/apurinic-apyrimidinic endonuclease 1 (REF1/APEX1), NTH endonuclease III-like 1 (NTHL1), 8-oxoguanine DNA glycosylase (OGG1), PARP1) and of the scaffold protein XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) were investigated in familial (BRCA-related and not) and sporadic breast cancer cases. Furthermore, miR17 expression was measured because of its role in the epigenetic regulation of BRCA1. Gene expression was evaluated in BRCA1-mutated cell lines, SUM149PT and SUM1315MO2, and in a BRCA1-proficient triple-negative MDA-MB-231 cell line. A cohort of 27 familial and 16 sporadic breast cancer patients was then examined to confirm results obtained from the cell line model. APEX1/REF1 was found to be upregulated in familial BRCA-wild-type and sporadic cases, indicating this enzyme as a potential therapeutic target. Furthermore, XRCC1 was overexpressed in BRCAX patients; consequently, we suggest to test the effectiveness of inhibitors targeting two different BER components in preclinical studies. XRCC1, which is also involved in the non-homologous end-joining pathway, was found to be downregulated in BRCA2-related patients concurrently with no change in PARP1 expression. Interestingly, no difference in PARP1 and miR17 expression was found in BRCA-related and sporadic breast cancer cases. PARP1 and miR17 could therefore be further investigated as molecular biomarkers of 'BRCAness' phenotype, indicating patients which could really benefit from PARP inhibitor therapies.


Biomarkers, Tumor/metabolism , DNA Repair , MicroRNAs/metabolism , Triple Negative Breast Neoplasms/metabolism , Adult , Aged , Animals , BRCA1 Protein/genetics , BRCA2 Protein/genetics , Biomarkers, Tumor/genetics , Cell Line, Tumor , Computational Biology , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , DNA Repair/genetics , DNA-(Apurinic or Apyrimidinic Site) Lyase/genetics , DNA-(Apurinic or Apyrimidinic Site) Lyase/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Databases, Genetic , Deoxyribonuclease (Pyrimidine Dimer)/genetics , Deoxyribonuclease (Pyrimidine Dimer)/metabolism , Female , Genetic Predisposition to Disease , HEK293 Cells , Humans , Mice , Middle Aged , Mutation , Phenotype , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/genetics , Poly(ADP-ribose) Polymerases/metabolism , Transfection , Triple Negative Breast Neoplasms/genetics , Triple Negative Breast Neoplasms/pathology , X-ray Repair Cross Complementing Protein 1
10.
J Eur Acad Dermatol Venereol ; 28(12): 1623-32, 2014 Dec.
Article En | MEDLINE | ID: mdl-23962152

BACKGROUND: Psoriasis can have cumulative physical and psychosocial effects preventing sufferers from achieving their full-life potential. Few studies have addressed the impact of psoriasis on work-related characteristics. OBJECTIVE: To evaluate the impact of psoriasis on education prospects and work limitations in patients with moderate-to-severe psoriasis. METHODS: This study was conducted in 29 dermatology centres across Italy. Information was collected by questionnaire during office visits. RESULTS: A total of 787 patients (64% male, aged 50 years) completed the questionnaire. At the time of the survey, mean Psoriasis Area and Severity Index (PASI) score and disease duration were 10 and 19 years respectively. Current smokers had higher PASI scores compared to non-smokers (10.8 vs. 9.4, P = 0.02). Plaque psoriasis was the most frequently described (91.2%). Fifty-five percent of patients had limited expectations of career progression. Similarly, in 42% of cases, psoriasis reduced the prospects of improvement in employment status and 35% of patients reported having reduced earning potential. Approximately 60% of patients reported that psoriasis localized to their hands or feet caused work limitations, whilst in about 25%, it caused them to quit their job. Approximately 37% of patients reported having lost between 3-10 work days in the past 3 months due to clinical assessment or treatment. Logistic regression revealed that gender, low standard of education, number of localizations, shame, anger and self-esteem were predictors significantly associated with limitations in work. CONCLUSIONS: Moderate-to-severe psoriasis has a profound negative impact on the employment capacity of patients in Italy. Psoriasis also contributes to days lost from work, affects job opportunity, career prospects and revenue potential.


Psoriasis/physiopathology , Workplace , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged
11.
Int J Immunopathol Pharmacol ; 26(3): 801-6, 2013.
Article En | MEDLINE | ID: mdl-24067481

Buckwheat allergy is considered a rare food allergy outside of Asia. In Europe, buckwheat has been described mainly as a hidden allergen. Data on the prevalence of buckwheat hypersensitivity in non-Asian countries is very poor. The aim of this multicenter study was to evaluate the prevalence of buckwheat sensitization and its association with other sensitizations among patients referred to allergy clinics in different geographic areas of Italy. All patients referred to 18 Italian allergy clinics from February through April 2011 were included in the study and evaluated for sensitization to buckwheat and other allergens depending on their clinical history. A total of 1,954 patients were included in the study and 61.3 percent of them were atopic. Mean prevalence of buckwheat sensitization was 3.6 percent with significant difference between Northern (4.5 percent), Central (2.2 percent) and Southern (2.8 percent) regions. This is, to our knowledge, the largest epidemiological survey on buckwheat allergy reported outside of Asia. Buckwheat is an emerging allergen in Italy, being more frequently associated to sensitization in Northern regions.


Allergens , Fagopyrum/adverse effects , Food Hypersensitivity/epidemiology , Adult , Female , Food Hypersensitivity/diagnosis , Food Hypersensitivity/immunology , Humans , Italy/epidemiology , Male , Middle Aged , Predictive Value of Tests , Prevalence , Referral and Consultation , Skin Tests , Young Adult
12.
J Biol Regul Homeost Agents ; 27(1): 131-41, 2013.
Article En | MEDLINE | ID: mdl-23489693

We studied the behaviour of three novel human sporadic melanoma cell lines (hmel1, hmel9, hmel11) extracted from tumors with different degrees of malignancy, concerning the cell signalling pathways controlled by MC1R, BRAF, NRAS and ß-catenins. The novel cell lines were compared to metastatic cell lines (HBL, LND1), wild type (wt) for MC1R and BRAF genes, that have been extensively characterised and were used as control. All the novel cell lines have silent or no MC1R mutations even though MC1R signalling is severely impaired. Conversely, they harbour BRAF mutations at the V600 residue. These mutations determine a constitutive ERK phosphorylation in all the three cell lines. Our new melanoma cell lines were BRAF mutated in hetero- and homozygosis, even with a wild type MC1R, and unresponsive to NDP-MSH treatment. Quantity and subcellular localization of ß-catenin were analyzed in both novel and control cell lines. In HBL and LND1 there were high levels of beta-catenin distributed in the cytoplasm/nucleus, while in the novel melanoma cell lines ß-catenins were less abundant and seemed to be located at the plasma membrane/cytoplasm and absent in the nucleus. We sequenced beta-catenin cDNA for all the melanoma cell lines, and found mutations in HBL, LND1 and hmel1, while hmel9 and hmel11 were wt. We found that beta-catenin levels were not influenced by the RAS/RAF/MAPK pathway because inhibition with PD98059 (a MEK inhibitor) did not produce any effect on beta-catenin stability and/or localization.


Melanoma/metabolism , Proto-Oncogene Proteins B-raf/metabolism , Receptor, Melanocortin, Type 1/metabolism , Signal Transduction , beta Catenin/metabolism , Blotting, Western , Cell Line, Tumor , Genotype , Humans , MAP Kinase Signaling System/drug effects , Melanoma/pathology , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Protein Transport/drug effects , Receptor, Melanocortin, Type 1/genetics , Signal Transduction/drug effects , Subcellular Fractions/drug effects , Subcellular Fractions/enzymology , alpha-MSH/analogs & derivatives , alpha-MSH/pharmacology
13.
J Biol Regul Homeost Agents ; 25(2): 239-47, 2011.
Article En | MEDLINE | ID: mdl-21880213

We isolated two novel cell lines from different types of sporadic human malignant melanoma: the hmel1 line was obtained from a melanoma skin metastasis and the hmel9 cell line from a primary superficial spreading melanoma. The karyotype and pigmentation parameters were assessed in these cell lines. Cytogenetic analysis in early stages of culture revealed that both cell lines had chromosome instability and simultaneous growth of heteroploid subpopulations. The molecular analysis of some genes involved in melanoma showed that both cell lines harbor BRAF mutations. The unpigmented hmel1 and the pigmented hmel9 lines were found to express the tyrosinase gene. The tyrosine hydroxylase activity was detectable only in hmel9 cells and practically absent in the hmel1 cell line. This activity was found to be correlated with the relative tyrosinase protein amount in both melanoma cell lines. The biological behaviour in the two melanoma cell lines, derived from two different types of melanoma lesions displaying distinct clinical and histopathological features, confirms the heterogeneous characteristics of sporadic melanoma. Similarities and/or differences between cell lines extracted from different melanoma cases could be useful in the future for diagnostic, prognostic and therapeutic purposes.


Cell Line, Tumor/cytology , Gene Expression Regulation, Neoplastic , Melanoma, Amelanotic/genetics , Melanoma/genetics , Monophenol Monooxygenase/metabolism , Proto-Oncogene Proteins B-raf/metabolism , Skin Neoplasms/genetics , Biomarkers/analysis , Chromosomal Instability , Cytogenetic Analysis , Genetic Variation , Humans , Karyotyping , Melanoma/diagnosis , Melanoma/pathology , Melanoma, Amelanotic/diagnosis , Melanoma, Amelanotic/pathology , Monophenol Monooxygenase/genetics , Pigmentation/genetics , Polyploidy , Prognosis , Proto-Oncogene Proteins B-raf/genetics , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology
14.
Allergy ; 66(2): 264-70, 2011 Feb.
Article En | MEDLINE | ID: mdl-20804471

BACKGROUND: Buckwheat allergy is a rare food allergy in Europe and North America, whereas it is often described and studied in Asia. The aim of this study was to describe a series of patients with proven buckwheat allergy evaluated in an Italian allergy clinic. Co-sensitization to other food and inhalant allergens and immunoblotting profiles of buckwheat-allergic patients were studied. METHODS: Patients with suspected buckwheat allergy who attended the allergy clinic between January 1, 2006, and September 30, 2008, were evaluated. All patients underwent skin prick tests for a standard panel of inhalant and food allergens, prick-by-prick with buckwheat flour, buckwheat-specific IgE determinations, and double-blind placebo-controlled food challenge (DBPCFC) with buckwheat flour. Immunoblotting with buckwheat flour extract was performed on sera from buckwheat-allergic patients. RESULTS: Among 72 patients with suspected buckwheat allergy, 30 (41.7%) were sensitized to buckwheat and 24 had a positive DBPCFC. The mean buckwheat IgE level was 6.23 kUA/l (range, 0.16 to >100 kUA/l). Several IgE-binding proteins were identified and grouped into three patterns: a 16-kDa band in patients with predominantly gastrointestinal symptoms with grass and wheat flour co-sensitization, a 25-kDa band in patients with predominantly cutaneous symptoms and a low frequency of co-sensitization, and a 40-kDa band in patients with anaphylaxis and a low frequency of co-sensitization. CONCLUSIONS: Buckwheat allergy is an emerging food allergy in Italy. We identified three distinct patterns of clinical and laboratory characteristics, suggesting that specific allergens could be more frequently associated with clinical manifestations of different severity.


Allergens/analysis , Fagopyrum/immunology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/immunology , Adolescent , Adult , Double-Blind Method , Female , Humans , Immunoblotting , Immunoglobulin E/analysis , Italy/epidemiology , Male , Middle Aged , Skin Tests , Young Adult
16.
Clin Exp Allergy ; 40(11): 1642-7, 2010 Nov.
Article En | MEDLINE | ID: mdl-20726860

BACKGROUND: Allergen exposure may increase airway oxidative stress, which causes lipid membrane peroxidation and an increased formation of 8-isoprostane. OBJECTIVE: The aim of the study was to investigate oxidative stress induced by allergen challenge in mild asthmatics, by measuring 8-isoprostane in exhaled breath condensate (EBC), and to examine their relationship with mediators derived from arachidonic acid. Methods 8-isoprostane, cysteinyl leukotrienes (cys-LTs) and prostaglandin E2 (PGE(2) ) concentrations in EBC were measured at baseline and after allergen challenge in 12 patients with mild allergic asthma sensitized to cat allergen. RESULTS: At 24 h after allergen challenge, compared with baseline values, EBC 8-isoprostane increased [48.64 pg/mL (44.14-53.61) vs. 21.56 pg/mL (19.92, 23.35), P<0.001], cys-LTs increased [27.37 pg/mL (24.09-31.10) vs. 13.28 pg/mL (11.32, 15.57), P<0.001] and PGE(2) decreased [18.69 pg/mL (12.26, 28.50) vs. 39.95 pg/mL (34.37, 46.43), P<0.001]. The trend of increasing 8-isoprostane after allergen challenge was significantly correlated with the trend of increasing cys-LTs (R(2) =0.85, P<0.001) whereas the trend of decreasing PGE(2) after allergen challenge was significantly correlated with the trend of increasing cys-LTs (R(2) =0.52, P=0.001). CONCLUSIONS AND CLINICAL RELEVANCE: The increase in EBC 8-isoprostane observed after allergen challenge indicates that allergen exposure increases airway oxidative stress in allergic asthma. The strict correlation between cys-LTs and 8-isoprostane underlines the relationship between allergic inflammation and oxidative stress. A shift of arachidonic acid metabolism towards lipoxygenase pathway is induced by the allergen challenge. Airway oxidative stress occurs after allergen challenge even in patients with mild intermittent allergic asthma.


Allergens/administration & dosage , Asthma/metabolism , Breath Tests , Exhalation , Lipid Peroxidation , Lung/metabolism , Oxidative Stress , Administration, Inhalation , Adult , Animals , Asthma/diagnosis , Asthma/immunology , Asthma/physiopathology , Biomarkers/metabolism , Case-Control Studies , Cats , Dinoprost/analogs & derivatives , Dinoprost/metabolism , Dinoprostone/metabolism , Female , Forced Expiratory Volume , Humans , Leukotrienes/metabolism , Lung/immunology , Lung/physiopathology , Male , Middle Aged , Nitric Oxide/metabolism , Severity of Illness Index , Time Factors , Young Adult
17.
Opt Express ; 18(16): 16335-44, 2010 Aug 02.
Article En | MEDLINE | ID: mdl-20721020

We present a study of the optical properties of three-armed square nanospirals made of silver and realized as nanostructured thin films with Glancing Angle Deposition. Calculation of current flows in the nanospirals show excited resonant modes resembling those observed in U-shaped resonators. Four principal resonances were determined: near 200 THz and 480 THz for one polarization and 250 THz and 650 THz for the polarization orthogonal to the first one. In particular, a mode with anti-parallel current flow in opposite arms, associated with the observed resonance near 650 THz, indicates the existence of a magnetic-like resonance in the square nanospiral arrays. The robustness of the resonances against variations in the structural parameters of the nanospirals was investigated. This study revealed that the main parameter driving the position of the resonances was the overall dimension of the nanospiral, directly related to the length of their arms. Optical properties of a sample were measured by generalized spectroscopic ellipsometry at near-normal incidence, and evidence conversion between polarization states even for light polarized in the plane containing one of the arms in agreement with the numerical study. The measurements compared favorably to the results of the numerical simulations taking into account the disorder in the sample.


Computer Simulation , Light , Nanostructures/chemistry , Scattering, Radiation , Silver/chemistry , Equipment Design , Magnetics
18.
Osteoporos Int ; 21(8): 1323-30, 2010 Aug.
Article En | MEDLINE | ID: mdl-19809775

SUMMARY: A total of 507,671 people > or =65 experienced hip fractures between 2000 and 2005. In 2005, 94,471 people > or =65 were hospitalized due to hip fractures, corresponding to a 28.5% increase over 6 years. Most fractures occurred in patients > or =75 (82.9%; n = 420,890; +16% across 6 years), particularly in women (78.2%; n = 396,967). INTRODUCTION: We aimed to analyze incidence and costs of hip fractures in Italy over the last 6 years. METHODS: We analyzed the national hospitalization and DRG databases concerning fractures occurred in people > or =65 between 2000 and 2005. RESULTS: A total of 507,671 people > or =65 experienced hip fractures across 6 years, resulting in about 120,000 deaths. In year 2005 94,471 people aged > or =65 were hospitalized due to hip fractures, corresponding to a 28.5% increase over 6 years. The majority of hip fractures occurred in patients > or =75 (82.9%; n = 420,890; +16% across 6 years) and particularly in women (78.2%; n = 396,967). Among women, 84.2% of fractures (n = 334,223; +28.0% over 6 years) were experienced by patients > or =75, which is known to be the age group with the highest prevalence of osteoporosis, accounting for 68.6% of the overall observed increase in the total number of fractures. Hip fractures in men > or =75 increased by 33.1% (up to 16,540). Hospitalization costs increased across the six examined years (+36.1%) reaching 467 million euros in 2005, while rehabilitation costs rose up to 531 million in the same year. CONCLUSIONS: Hip fractures of the elderly are increasing and represent a major health problem in industrialized countries such as Italy.


Hip Fractures/epidemiology , Osteoporotic Fractures/epidemiology , Age Distribution , Aged , Diagnosis-Related Groups , Female , Health Care Costs/statistics & numerical data , Hip Fractures/rehabilitation , Hospitalization/statistics & numerical data , Hospitalization/trends , Humans , Incidence , Italy/epidemiology , Male , Middle Aged , Osteoporotic Fractures/rehabilitation , Sex Distribution
19.
J Chemother ; 21(3): 302-10, 2009 Jun.
Article En | MEDLINE | ID: mdl-19567351

This prospective study evaluated the frequency and severity of respiratory symptoms during the second respiratory syncytial virus (RSV) season in an italian cohort of preterm infants (< or = 35 weeks) who had received palivizumab prophylaxis in their first year of life (October 2004-April 2005) and who had not previously been hospitalized for RSV-induced lower respiratory tract infection (LRTI). infants were evaluated at enrolment (May-September 2005), in October/November 2005 and in April 2006. The occurrence of any respiratory episode, the rate of hospitalization for respiratory-related LRTI, total length of stay in hospital, physician-documented recurrent wheezing (>or = 3 physician-documented episodes of wheezing) and use of airway medication/antibiotics were recorded during follow-up. All infants had prior palivizumab prophylaxis during their first RSV season. In the total evaluable population (n=260), 32.3% of infants experienced at least one respiratory episode, 3.8% required short hospitalization because of LRTI, 8.5% had physician-documented recurrent wheezing, and 48.8% required airway medications/antibiotics during follow-up. in this study the rate of airway morbidity, hospitalization and physician-documented recurrent wheezing during the second RSV season was low among preterm infants who had received prior palivizumab prophylaxis.


Antibodies, Monoclonal/therapeutic use , Hospitalization/statistics & numerical data , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Tract Diseases/epidemiology , Antibodies, Monoclonal, Humanized , Cohort Studies , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Infant, Premature , Male , Palivizumab , Prospective Studies , Respiratory Sounds , Respiratory Tract Infections/epidemiology
...